Aurobindo Pharma Ltd.
| BSE: 524804 | Sector: Health care |
| NSE: AUROPHARMA | ISIN Code: INE406A01037 |
| BSE 00:00 | 24 May | 538.60 |
-20.25 (-3.62%) |
OPEN
559.95 |
HIGH
559.95 |
LOW
537.60 |
| NSE 00:00 | 24 May | 538.55 |
-20.25 (-3.62%) |
OPEN
557.95 |
HIGH
557.95 |
LOW
537.00 |
| OPEN | 559.95 |
| PREVIOUS CLOSE | 558.85 |
| VOLUME | 90578 |
| 52-Week high | 1043.00 |
| 52-Week low | 521.00 |
| P/E | 20.69 |
| Mkt Cap.(Rs cr) | 31,557 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Aurobindo Pharma Ltd. (AUROPHARMA) - Market Capital
Market Cap
| COMPANY | LATEST(Rs) | CHG(%) | 52 Wk High | 52 Wk Low | MKT-CAP (RS CR) |
| Sun Pharma.Inds. | 910.20 | -1.22 | 966.90 | 652.75 | 218384.28 |
| Divi's Lab. | 3662.05 | -6.04 | 5425.00 | 3650.00 | 97209.12 |
| Cipla | 970.50 | -0.01 | 1083.15 | 850.00 | 78299.94 |
| Dr Reddy's Labs | 4351.10 | 1.80 | 5613.65 | 3655.00 | 72411.01 |
| Apollo Hospitals | 3632.40 | -2.40 | 5930.70 | 3122.90 | 52226.65 |
| Gland Pharma | 2871.65 | -3.67 | 4350.00 | 2801.00 | 47267.36 |
| Torrent Pharma. | 2592.50 | -0.90 | 3304.45 | 2485.00 | 43870.29 |
| Piramal Enterp. | 1809.95 | -4.00 | 3013.00 | 1687.30 | 43194.46 |
| Biocon | 329.15 | -2.56 | 420.25 | 314.90 | 39517.75 |
| Abbott India | 18191.80 | 2.47 | 23902.30 | 15525.00 | 38657.57 |
| Zydus Lifesci. | 368.15 | 1.59 | 668.85 | 319.40 | 37687.52 |
| Max Healthcare | 365.05 | -0.15 | 472.60 | 205.00 | 35396.34 |
| Alkem Lab | 2932.40 | -1.76 | 4067.70 | 2835.00 | 35056.84 |
| Aurobindo Pharma | 538.60 | -3.62 | 1043.00 | 521.00 | 31556.57 |
| Laurus Labs | 567.15 | -0.94 | 723.55 | 433.20 | 30475.81 |
| Lupin | 601.15 | -2.79 | 1267.50 | 596.50 | 27322.27 |
| Glaxosmi. Pharma | 1553.75 | -0.08 | 1917.00 | 1433.05 | 26322.08 |
| Ipca Labs. | 955.60 | -2.20 | 1383.55 | 917.00 | 24243.57 |
| Syngene Intl. | 547.25 | -2.11 | 699.95 | 508.10 | 21968.26 |
| Pfizer | 4258.60 | -3.38 | 6164.80 | 4077.80 | 19483.10 |
Quick Links for Aurobindo Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
